Page last updated: 2024-11-05

thalidomide and Cervical Fusion Syndrome

thalidomide has been researched along with Cervical Fusion Syndrome in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mündnich, K1
Terrahe, K1

Other Studies

2 other studies available for thalidomide and Cervical Fusion Syndrome

ArticleYear
The dysplasias of the middle and the inner ear in different types of malformation.
    Proceedings of the Royal Society of Medicine, 1974, Volume: 67, Issue:12 Pt 1

    Topics: Abnormalities, Drug-Induced; Congenital Abnormalities; Ear, Inner; Ear, Middle; Humans; Klippel-Feil

1974
[Diagnosis of malformations of the ear and temporal bone].
    Archiv fur klinische und experimentelle Ohren- Nasen- und Kehlkopfheilkunde, 1972, Volume: 202, Issue:1

    Topics: Abducens Nerve; Abnormalities, Drug-Induced; Abnormalities, Multiple; Audiometry; Craniofacial Dysos

1972